COVID-19 (Temporary Measures) (Performances and Other Activities — Control Order) (Amendment) Regulations 2022

No. S 65

COVID‑19 (Temporary Measures) Act 2020

COVID-19 (Temporary Measures)
(Performances and Other Activities —
Control Order) (Amendment)
Regulations 2022

In exercise of the powers conferred by section 34(1) of the COVID‑19 (Temporary Measures) Act 2020, the Minister for Health makes the following Regulations:

Citation and commencement

1. These Regulations are the COVID‑19 (Temporary Measures) (Performances and Other Activities — Control Order) (Amendment) Regulations 2022 and come into operation on 1 February 2022.

Amendment of regulation 7A

2. Regulation 7A of the COVID‑19 (Temporary Measures) (Performances and Other Activities — Control Order) Regulations 2020 (G.N. No. S 927/2020) (called in these Regulations the principal Regulations) is amended —

(a)

by deleting sub‑paragraph (b) of paragraph (1) and substituting the following sub‑paragraph:

“(b)

every performer playing a wind musical instrument or singing (whether or not when wearing a mask) has a cleared status (general) or cleared status (special) that is current under the Infectious Diseases (COVID‑19 Access Restrictions and Clearance) Regulations 2021 and, within the period of 24 hours before the end of the period of the live performance —

(i)	he or she undergoes an approved test or approved tests or a supervised self‑administered antigen rapid test; and
(ii)	his or her approved test result is treated under those Regulations either as negative for SARS‑CoV‑2 or an atypical finding for SARS‑CoV‑2, or the result from the supervised self‑administered antigen rapid test shows no presence of SARS‑CoV‑2 in that individual; and”; and

(b)

by inserting, immediately after paragraph (2), the following paragraph:

“(3) For the purposes of this regulation —

“approved antigen rapid test” means an antigen rapid test performed in Singapore in relation to an individual using any of the test products specified in the Schedule to the Infectious Diseases (Antigen Rapid Test Providers) Regulations 2021 (G.N. No. S 267/2021), the purpose of which is to test for the presence of SARS‑CoV‑2 in that individual;

“approved supervisor” means the person having the charge, management or control of the room or place where the live performance takes place or is to take place, either on the person’s own account or as agent of another person, during that period;

“supervised self‑administered antigen rapid test” means —

(a)	the individual removing a respiratory specimen from the lining of his or her oral or nasal passage under the supervision of an approved supervisor for the purpose of subjecting the respiratory specimen to an approved antigen rapid test under paragraph (b);
(b)	the individual then subjecting, under the supervision of an approved supervisor, the respiratory specimen removed under paragraph (a) to an approved antigen rapid test for the purpose of testing for the presence of SARS‑CoV‑2 in that individual; and
(c)	the individual or approved supervisor then ascertaining the results of the approved antigen rapid test and recording the results, even if uncertain or invalid.”.

Amendment of regulation 12A

3. Regulation 12A of the principal Regulations is amended by deleting paragraph (2) and substituting the following paragraph:

“(2) In addition to paragraph (1), an occupier of a live performance venue where a live performance is taking place or is to take place must establish and maintain, during the period of the live performance, enhanced entry controls with respect to the live performance venue where that live performance venue is a restricted place within the meaning of the Infectious Diseases (COVID‑19 Access Restrictions and Clearance) Regulations 2021.”.

Amendment of regulation 19

4. Regulation 19(1) of the principal Regulations is amended by deleting “7A(1)(b)(ii),”.

New regulation 21A

5. The principal Regulations are amended by inserting, immediately after regulation 21, the following regulation:

“Enhanced entry controls needed for media conference

21A.—(1) Without limiting regulation 21, a promoter of a media conference must establish and maintain, during the period of the media conference, enhanced entry controls with respect to the place where the media conference is held or to be held, where that place is a restricted place within the meaning of the Infectious Diseases (COVID‑19 Access Restrictions and Clearance) Regulations 2021.

(2) The enhanced entry controls with respect to a media conference or a place where a media conference is held or to be held, means a requirement to establish and maintain, during the period of the media conference, all reasonably practicable procedures and protocols that ensure that —

(a)	every recognised reporter for the media conference;
(b)	every interviewee at the media conference; and
(c)	any other individual mentioned in regulation 21(1)(d),

who enters or remains within that place during that media conference has a cleared status or is an uncleared junior.”.

[G.N. Nos. S 984/2020; S 1071/2020; S 41/2021; S 239/2021; S 276/2021; S 306/2021; S 327/2021; S 370/2021; S 378/2021; S 510/2021; S 525/2021; S 538/2021; S 585/2021; S 617/2021; S 717/2021; S 859/2021: S 890/2021; S 909/2021; S 983/2021]

Made on 30 January 2022.

NG HOW YUE

Permanent Secretary
(Health Development),
Ministry of Health,
Singapore.

[AG/LEGIS/SL/65C/2020/18 Vol. 3]

(To be presented to Parliament under section 34(4) of the COVID‑19 (Temporary Measures) Act 2020).

Search within Legislation